Effect of aripiprazole as an adjunct to atypical antipsychotics on weight and metabolic profile: a 12-week open-label trial

BACKGROUND: Atypical antipsychotics are widely prescribed, yet have been associated with weight gain and metabolic syndrome. AIM: To study the effect of adjunct low-dose aripiprazole on weight and metabolic parameters of subjects on atypical antipsychotics (olanzapine, clozapine or risperidone). MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Bhanu, Chee, Kok-Seng, Neo, Li-Qi, Tang, Charmaine, Hariram, Jayaraman, Tan, Geoffrey Chern-Yee, Verma, Swapna, Basu, Sutapa, Appan, Deva-Priya, Ting, Chan-Chun, Abdin, Edimansyah, Lee, Jimmy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504280/
https://www.ncbi.nlm.nih.gov/pubmed/34646440
http://dx.doi.org/10.1177/20451253211046765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8504280/
https://www.ncbi.nlm.nih.gov/pubmed/34646440
http://dx.doi.org/10.1177/20451253211046765

Ejemplares similares